557 related articles for article (PubMed ID: 25925959)
1. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
[TBL] [Abstract][Full Text] [Related]
2. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J
J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
[TBL] [Abstract][Full Text] [Related]
3. Topical adenosine increases the proportion of thick hair in Caucasian men with androgenetic alopecia.
Iwabuchi T; Ideta R; Ehama R; Yamanishi H; Iino M; Nakazawa Y; Kobayashi T; Ohyama M; Kishimoto J
J Dermatol; 2016 May; 43(5):567-70. PubMed ID: 26508659
[TBL] [Abstract][Full Text] [Related]
4. The topical penta-peptide Gly-Pro-Ile-Gly-Ser increases the proportion of thick hair in Japanese men with androgenetic alopecia.
Iwabuchi T; Takeda S; Yamanishi H; Ideta R; Ehama R; Tsuruda A; Shibata H; Ito T; Komatsu N; Terai K; Oka S
J Cosmet Dermatol; 2016 Jun; 15(2):176-84. PubMed ID: 27030543
[TBL] [Abstract][Full Text] [Related]
5. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
6. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
7. Contribution of hair density and hair diameter to the appearance and progression of androgenetic alopecia in Japanese men.
Ishino A; Takahashi T; Suzuki J; Nakazawa Y; Iwabuchi T; Tajima M
Br J Dermatol; 2014 Nov; 171(5):1052-9. PubMed ID: 24981717
[TBL] [Abstract][Full Text] [Related]
8. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
12. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Bassiouny EA; El-Samanoudy SI; Abbassi MM; Nada HR; Farid SF
Arch Dermatol Res; 2023 Jul; 315(5):1293-1304. PubMed ID: 36571611
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
16. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate.
Faghihi G; Iraji F; Rajaee Harandi M; Nilforoushzadeh MA; Askari G
Acta Dermatovenerol Croat; 2013; 21(3):155-9. PubMed ID: 24183218
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
20. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
